UCB SA (UCBJY) Q2 2026 Earnings Call July 30, 2026 8:00 AM EDT
Company Participants
Yvonne Naughton – Head of Investor Relations
Jean-Christophe Tellier – CEO & Executive Director
Emmanuel Caeymaex – Executive VP & Head of Patient Evidence
Fiona du Monceau – Executive VP of Patient Impact & Chief Commercial Officer
Sandrine Dufour – Executive VP & CFO
Conference Call Participants
Peter Verdult – BNP Paribas, Research Division
Sarita Kapila – Morgan Stanley, Research Division
Sofia Graeff Buhl-Nielsen
Xian Deng – UBS Investment Bank, Research Division
Charles Pitman – Barclays Bank PLC, Research Division
Charlie Haywood – BofA Securities, Research Division
Kerry Holford – Joh. Berenberg, Gossler & Co. KG, Research Division
Guofang Li – Wolfe Research, LLC
Michael Leuchten – Jefferies LLC, Research Division
Rajan Sharma – Goldman Sachs Group, Inc., Research Division
Stacy Ku – TD Cowen, Research Division
Qize Ding – Rothschild & Co Redburn, Research Division
Presentation
Yvonne Naughton
Head of Investor Relations
A warm welcome to UCB’s Half Year 2026 Presentation Conference Call and webcast for investors and analysts. I’m Yvonne Naughton, Head of Investor Relations. Before I hand over to Jean-Christophe and members of our executive team, I would like to cover some housekeeping items. Today’s presentation is available for download on the Investor Relations section of our website. The presentation and Q&A session are subject to the disclaimer and safe harbor statement contained on Slide 2 of the presentation.
Moving to Slide 3. Our speakers today are Jean-Christophe Tellier, Chief Executive Officer; Emmanuel Caeymaex, Executive Vice President and Head of Patient Evidence; Fiona du Monceau, Executive Vice President and Chief Commercial Officer; and Sandrine Dufour, Executive Vice President and Chief Financial Officer. Following our prepared remarks, we will open the line for questions. As usual, we will try to address as many questions as we can. So please limit your questions to allow others a fair chance to participate in the Q&A. And with that, I’ll hand over to you Jean-Christophe.
